Clinical Trial Update: Effect of Photobiomodulation Treatment in Individuals With Multiple Sclerosis: [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating photobiomodulation treatment in individuals with Multiple Sclerosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University of Nove de Julho | Conditions: Multiple Sclerosis | Phase 2 | Status: UNKNOWN